Dublin, July 23, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/l8bdqg/diagnostic) has announced the addition of the "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by Lead Type - Global Forecast to 2020" report to their offering.
The global diagnostic electrocardiograph (ECG) market is segmented into three major segments, namely, holter monitor, resting, and stress type diagnostic ECG devices. The overall market was valued at $3,683 million in 2013 and is poised to grow at a CAGR of 5.7% by 2020. The market is driven by the rise in geriatric population, growing incidences of lifestyle diseases, and technological advancements. However, the decline of reimbursement policies will restrain the growth of this market to an extent. The holter monitor ECG devices will be the most fruitful segment for the companies to invest in the coming years.
The resting ECG devices segment was the leading segment owing to the expanding geriatric population and growing incidences of cardiac diseases and other lifestyle diseases such as diabetes and hypertension. The holter diagnostic ECG device on the other hand was the fastest growing segment and is expected to grow at a healthy pace in the coming years, driven by the advancements in technology.
While segmenting the market with respect to number of leads the 3-6 lead segment had the largest market share followed by the 12 lead segment. The 3-6 lead segment is also expected to grow at the fastest pace in the forecast period from 2013 to 2020. More number of leads captures more signals, thereby giving a detailed outlook. This makes it easier for providers to better interpret the electrical activity of the heart. Thus, 3-6 lead and 12-lead ECG device segments will grow at higher CAGRs than single-lead ECG devices.
With respect to the end users, the global diagnostic ECG market is divided into hospitals, home/ambulatory care research centers, diagnostic centers, rehabilitation centers, clinics, physician offices, and surgical centers. The hospital segment will observe a high growth due to the new technologies launched and the purchasing of an entire new suit of diagnostic ECG devices.
The geographic analysis reveals that North America accounted for the largest share in 2013. APAC, on the other hand will be the main focus of the market in the coming five years that will register a high growth rate for all the segments. Europe on the other hand will register a slow growth rate in the forecast period.
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Global Diagnostic ECG Market, By Product
6 Global Diagnostic ECG Market, By Lead Type
7 Global Diagnostic ECG Market, By End User
8 Global Diagnostic ECG Market, Geographical Analysis
9 Competitive Landscape
10 Company Profiles
- Cardionet Inc.
- Compumed Inc.
- Ge Healthcare
- Mindray Medical International Limited
- Mortara Instrument, Inc.
- Nihon Kohden Corporation
- Royal Philips Healthcare
- Schiller AG
- Spacelabs Healthcare Inc.
- Welch Allyn
For more information visit http://www.researchandmarkets.com/research/l8bdqg/diagnostic
CONTACT: Research and Markets Laura Wood, Senior Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Medical Devices
Source:Research and Markets